Insider Transaction Report for Core Laboratories Inc.

2026-04-07SEC Filing 4 (0001193125-26-145939)

This filing details insider transactions for Robert F. Martinovich, a director at Core Laboratories Inc. On April 1, 2026, Martinovich acquired 7,895 restricted shares of common stock, which vested at the end of a one-year period ending April 1, 2026, as per footnote F2. These shares were subject to a deferral election, with distribution of the vested portion to occur after separation from the Board, as noted in footnote F1. Additionally, a transaction code "M" indicates a disposal of 8,069 shares with a transaction code "A" for acquisition of 8,069 shares of common stock on the same date, with a post-transaction share count of 8,069. The price per share for these transactions was $0.0.